LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged informative decisions · clear

PTAB

USPTO Provides New Guidance on Motions to Amend During IPR

On June 1, 2018 the U.S. Patent and Trademark Office designated a Board order in Western Digital Corporation v. SPEX Technologies, Inc . as informative on the issue of Motions to Amend during an IPR. At the same time, the USPTO de-designated two previously…

June 15, 2018·PTAB·4 min read
PTAB

PTAB Clarifies 315(B) Positions With Informative Opinions

Board Continues to Provide Helpful Feedback on Best Practices The Patent Trial & Appeal Board (PTAB) has designated the following decisions, which involve 35 U.S.C. § 315(b), as informative. Luv N’ Care, Ltd. v. McGinley, Case IPR2017-01216…

January 17, 2018·PTAB·1 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data